| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_849b873488ec2cdb529cf36a6ecee3a8 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-20 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-20 |
| filingDate |
2019-09-11^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3522706bb1d506b4313a8f1e818cd0e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2eaa960e54c0ec6198187eda26e746c8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b8f6ed889ce17f7ea1ae2ca6210d36f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9706e471bed7dc3d20ac81f78cbba563
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f435fff5db02aa9e108003c96afd5fe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a4a5d9c2e99b7f5845ac21eda6d8ece
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_33fe37e20530687c553d7f05240a29bf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6cf6c76f024cfc7689ad2061cb6b49ac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90fe8e59e0eeff086ce9d7c59e310c91 |
| publicationDate |
2020-03-19^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2020055192-A2 |
| titleOfInvention |
Preparation method for quinoline-5, 8-dione derivative which is tgase 2 inhibitor |
| abstract |
The present invention relates to a preparation method for a quinoline-5, 8-dione derivative compound represented by chemical formula I, a stereoisomer of same or a pharmaceutically acceptable salt of same. A compound represented by chemical formula I of the present application has a TGase 2-inhibiting effect, and a pharmaceutical composition comprising same can be usefully employed in the prevention or treatment of disorders or diseases that are mediated by TGase 2 or react to the inhibition of TGase 2. |
| priorityDate |
2018-09-13^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |